How to optimize water purity at a reduced cost
Watch this expert on-demand webinar to learn how to maximize the efficiency of water preparation in your lab
Watch this expert on-demand webinar to learn how to maximize the efficiency of water preparation in your lab
Echo MS System delivers ultra-high throughput screening of up to 3 samples per second
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry
Join us on Tuesday, June 16, to learn how to improve overall method robustness and sensitivity for oligonucleotide method development
Join us on Thursday, June 18, to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
New kits support analysis of all organs and species on fresh/fixed frozen and FFPE samples
Join us on Tuesday, June 9, to explore the qualitative and quantitative characterization of mAb and protein stability, both in vitro and in vivo, by CE-MS and LC-MS
Advance your COVID-19 research with positive and negative SARS-CoV-2 samples
Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production
Olympus imaging systems empower next-generation cancer research at USC’s Ellison Institute
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research
Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers' specific analytical requirements
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
Harnessing the most powerful force in the fight against disease — natural human immunity
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus